Company:  EXAGEN INC. (XGN)
Form Type:  10-K
Filing Date:  3/25/2020 
CIK:  0001274737 
Address:  1261 LIBERTY WAY 
City, State, Zip:  VISTA, California 92081 
Telephone:  (760) 560-1501 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$12.75  
Change: 
0.04 (0.32%)  
Trade Time: 
Jul 02  
Market Cap: 
$161.16M
Trade XGN now with 

© 2020  
Description of Business
Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. We have developed and are commercializing a portfolio of innovative testing products under our AVISE® brand, several of which are based on our proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology. CB-CAPs assess the activation of the complement system, a biological pathway that is widely implicated across many autoimmune and autoimmune-related diseases, including systemic lupus erythematosus, or SLE. Our goal is to enable rheumatologists to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including SLE and rheumatoid arthritis, or RA.
Register and access this filing in:     
  FORM 10-K
    Part I.
      Item 1. Business
      Item 1A. Risk Factors
      Item 1B. Unresolved Staff Comments
      Item 2. Properties
      Item 3. Legal Proceedings
      Items 4. Mine Safety Disclosures
    Part II.
      Item 5. Market for Registrant's Common Equity, Related ...
      Item 6. Selected Financial Data
      Item 7. Management's Discussion and Analysis of Financial ...
        Results of Operations
      Item 7A. Quantitative and Qualitative Disclosures About ...
      Item 8. Financial Statements and Supplementary Data
      Item 9. Changes in and Disagreements with Accountants on ...
      Item 9A. Controls and Procedures
      Item 9B. Other Information
    Part III.
      Item 10. Directors, Executive Officers and Corporate Governance
      Item 11. Executive Compensation
      Item 12. Security Ownership of Certain Beneficial Owners and ...
      Item 13. Certain Relationships and Related Transactions, and ...
      Item 14. Principal Accountant Fees and Services
    Part IV
      Item 15. Exhibits and Financial Statement Schedules
    Report of Independent Registered Public Accounting Firm
    BALANCE SHEET
    INCOME STATEMENT
    STOCKHOLDERS EQUITY
    CASH FLOW
    Notes to Financial Statements
      Note 14. Subsequent Events
    Index to Exhibits
    Signatures
  EXHIBIT 10.27
  EXHIBIT 10.28
  EXHIBIT 10.29
  EXHIBIT 10.31
  EXHIBIT 10.32
  EXHIBIT 10.33
  EXHIBIT 10.36
  EXHIBIT 10.41
  EXHIBIT 23.1
    Consent of Independent Registered Public Accounting Firm
  EXHIBIT 31.1
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION OF CHIEF FINANCIAL OFFICER
  EXHIBIT 32.1
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER